Cash Flow Supernus Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
97.00
2.00
60.00
73.00
168.00
147.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2.00
-9.00
-24.00
3.00
-36.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
171.00
111.00
116.00
127.00
138.00
143.00
Cash Flow from Investing Activities
-189.00
268.00
-216.00
-81.00
-34.00
-157.00
Cash Flow from Financing Activities
12.00
-397.00
-10.00
-130.00
3.00
3.00
Net Cash Inflow / Outflow
-5.00
-18.00
-110.00
-85.00
107.00
-10.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Supernus Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
97.87
-298.408
395.00
132.80%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2.052
11.635
-13.00
-117.64%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
171.951
-225.97
396.00
176.09%
Cash Flow from Investing Activities
-189.867
-574.817
385.00
66.97%
Cash Flow from Financing Activities
12.193
1010.435
-998.00
-98.79%
Net Cash Inflow / Outflow
-5.723
209.648
-214.00
-102.73%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 54.79% vs -4.91% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
171.95
111.08
54.79%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
